Volume 28, Issue 4 (10-2025)                   J Arak Uni Med Sci 2025, 28(4): 246-252 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fatemi Nejad R, Dayer M R, Dorostghoal M, Parishani M R. Effects of Intraperitoneal Injection of Botox on Biochemical and Structural Parameters of the Kidneys of Female Wistar Rats. J Arak Uni Med Sci 2025; 28 (4) :246-252
URL: http://jams.arakmu.ac.ir/article-1-7921-en.html
1- Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran
2- Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran , mrdayer@scu.ac.ir
Abstract:   (377 Views)
Introduction: Botulinum neurotoxin protein (Botox) is widely used for cosmetic purposes to reduce facial wrinkles without regard to its side effects. The present study was conducted to investigate the effects of Botox on blood biochemical factors and the kidney tissue structure of female rats.
Methods: In this study, 28 adult female Wistar rats were selected and randomly divided into four groups (n = 7). The first three groups received intraperitoneal injections of Botox (in the lower third of the abdomen, one centimeter below and to the left of the navel) at doses of 4, 6, and 8 units, respectively, while the fourth group (the control group) received a saline injection. Then the animals were kept in the animal house for three months with full access to food and water at a temperature of 22°C and a 12-hour light-dark cycle. Following a 24-hour fasting period at the end of the study, blood samples were collected via cardiac puncture under ether anaesthesia. Then, the animals were euthanized without pain, and their kidney tissue samples were extracted for histological examination.
Results: Biochemical results indicated a significant increase in serum creatinine levels following injection with 6 and 8 units of Botox, indicating renal impairment. Although the increase in the amount of serum uric acid levels compared to the control group did not reach statistical significance at the 95% confidence level (P < 0.05), it showed significance at the 94% level (p < 0.06), suggesting primary renal damage. Histopathological examination demonstrated that intraperitoneal injection of 8 units of Botox induced scattered and limited structural alterations in renal tissue, including vacuolar degeneration of tubular epithelial cells.
Conclusions: The results of this research show that the long-term and repeated use of Botox may cause significant renal damage in addition to local lesions and threaten a person's life.
 
Full-Text [PDF 860 kb]   (82 Downloads)    
Type of Study: Original Atricle | Subject: Basic Sciences
Received: 2025/01/3 | Accepted: 2025/05/11

References
1. Roland SB, Pripp AH, Msomphora MR, Kvarstein G. The efficacy of botulinum toxin A treatment for tension-type or cervicogenic headache: a systematic review and meta-analysis of randomized, placebo-controlled trials. Scand J Pain. 2021;21(4):635-52. pmid: 34090319. doi: 10.1515/sjpain-2021-0038.
2. Shelley WB, Talanin NY, Shelley ED. Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol. 1998;38(2 Pt 1):227-9. pmid: 9486678. doi: 10.1016/s0190-9622(98)70242-7.
3. Bhatia KP, Münchau A, Brown P. Botulinum toxin is a useful treatment in excessive drooling in saliva. J Neurol Neurosurg Psychiatry. 1999;67(5):697. pmid: 10577041. doi: 10.1136/jnnp.67.5.697.
4. Nigam PK, Nigam A. Botulinum toxin. Indian J Dermatol. 2010;55(1):8-14. pmid: 20418969. doi: 10.4103/0019-5154.60343.
5. Blumetti FC, Belloti JC, Tamaoki MJ, Pinto JA. Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy. Cochrane Database Syst Rev. 2019;10(10):CD001408. pmid: 31591703. doi: 10.1002/14651858.CD001408.pub2.
6. Jahanbazi A, Asgari K, Chitsaz A, Mehrabi H, Asemi N. Investigating the effectiveness of medication comparing to medication plus EMG biofeedback on depression, anxiety and stress in females with chronic focal dystonia [in Persian]. J Arak Uni Med Sci 2013;16(6):40-50.
7. Uchiyama A, Yamada K, Perera B, Ogino S, Yokoyama Y, Takeuchi Y, Ishikawa O, Motegi S. Protective effect of botulinum toxin A after cutaneous ischemia-reperfusion injury. Sci Rep. 2015;5:9072. pmid: 25766279. doi: 10.1038/srep09072.
8. Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr. 2005;63(1):180-5. pmid: 15830090. doi: 10.1590/s0004-282x2005000100035.
9. Bakheit AM, Ward CD, McLellan DL. Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases. J Neurol Neurosurg Psychiatry. 1997;62(2):198. pmid: 9048725. doi: 10.1136/jnnp.62.2.198.
10. Crowner BE, Torres-Russotto D, Carter AR, Racette BA. Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature. Clin Neuropharmacol. 2010 33(5):243-7. pmid: 20852412. doi: 10.1097/WNF.0b013e3181f5329e.
11. Witmanowski H, Błochowiak K. The whole truth about botulinum toxin - a review. Postepy Dermatol Alergol. 2020;37(6):853-61. pmid: 33603602. doi: 10.5114/ada.2019.82795.
12. Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z. Diffusion, spread, and migration of botulinum toxin. Mov Disord. 2013;28(13):1775-83. pmid: 23868503. doi: 10.1002/mds.25582.
13. Roh TS, Jung BK, Yun I, Lew DH, Kim YS. Effect of botulinum toxin A on vasoconstriction and sympathetic neurotransmitters in a murine random pattern skin flap model. Wound Repair Regen 2017;25(1):75–85. doi: 10.1111/wrr.12501.
14. Brin MF, Burstein R. Botox (onabotulinumtoxinA) mechanism of action. Medicine (Baltimore). 2023;102(S1):e32372. doi:10.1097/MD.0000000000032372.
15. Chang YH, Hsiao PJ, Chi-Ping H, Wu HC, Hsieh PF, Chou ECL. A comparative observational study to evaluate the efficacy of mid-urethral sling with botulinum toxin a injection in urinary incontinence patients. Toxins 2020;12(6):365. doi:10.3390/toxins12060365.
16. Rao AK, Sobel J, Chatham-Stephens K, Luquez C. Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021. MMWR Recomm Rep 2021;70(2):1–30. pmid: 33956777 doi:10.15585/mmwr.rr7002a1.
17. Mitchell SD, Sidiropoulos C. Therapeutic applications of botulinum neurotoxin for autonomic symptoms in parkinson's disease: an updated review. Toxins (Basel). 2021; 13(3):226. pmid: 33808714. doi:10.3390/toxins13030226.
18. US Food and Drug Administration. Botox Linked to Respiratory Failure and Death, FDA Advises. ScienceDaily. 10 February 2008; [Cited 2024 December 26] Available from: www.sciencedaily.com/releases/2008/02/080209090530.htm
19. Rashidi R, Mohamadzadeh V, Milani N, Jarahi L, Dadpour B. Acute Kidney Injury in Poisoned Patients Admitted to ICU. Int J Med Toxicol Forensic Med. 2020;10(4):30471. doi: 10.32598/ijmtfm. v10i4.30471.
20. Novo Pereira I, Durão S, Hassan H, Braga AC, Almeida AM, Manso AC, et al. Botulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions: a systematic review of clinical research. J Neural Transm (Vienna). 2025. pmid: 40035830 doi:10.1007/s00702-024-02869-w.
21. Navarro-Gonzales P, Ganz T, Pergola PE, Zuk A, Dykstra K. Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease. Clin Pharmacol Ther. 2024;116(4):1052-61. pmid: 38924087. doi:10.1002/cpt.3342.
22. Hajihashemi S, Rajabi R, Ghiasabadi Farahani A. The oral post-treatment effect of hydroethanolic extract of origanum vulgare on acute kidney injury caused by gentamicin in rats [in Persian]. J Arak Uni Med Sci. 2019;22(5):18-31. doi:10.32598/JAMS.22.5.18
23. Juhi JS, Imran A, Alawadi M, Al-Muswie R. Effect of botulinum toxins injection on liver enzyme and histochange of liver and kidney of female rats. Journal of Global Pharma Technology. 2019;11(7):133-8.
24. Fereydouni T, Hajihashemi S, Yousefichaijan P, Rahbari A. Protective effects of vitamin c concomitant treatment on deferasirox-induced renal toxicity in rats [in Persian]. J Arak Uni Med Sci 2020;23(6):926-43. doi: 10.32598/jams.23.6.62.7
25. Silva JS de LM, Souza F de AL, Barros MEG de, et al. Hepatic and renal evaluation in rats submitted to chronic administration of botulinum toxin tip A in the submandibular salivary gland. RSD;11(10):e148111032423. | doi: doi.org/10.33448/rsd-v11i10.32423
26. El Hidan MA, Touloun O, El Hiba O, Chait A, Eddine Hafid J, Boumezzough A. Behavioral, histopathological and biochemical impairments observed in mice envenomed by the scorpion: Hottentota gentili (Pallary, 1924). Toxicon. 2015;103:19-29. pmid: 26091876. doi: 10.1016/j.toxicon.2015.06.013.
27. Shotaev VV, Doshkhokloeva KR, Vakhidova PH, Dudkin RA, Kostiukova DY, Ionova SM, et al. Effect of Stress on Hormone Levels in the Blood Serum of Rats with Alimentary Obesity. Pharmacophore. 2024; 15(3):47-52. doi:10.51847/kqAKevHg3e.
28. Schyman P, Printz RL, AbdulHameed MDM, Estes SK, Shiota C, Shiota M, et al. A toxicogenomic approach to assess kidney injury induced by mercuric chloride in rats. Toxicology. 2020;442:152530. pmid: 32599119. doi: 10.1016/j.tox.2020.152530.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb